Paid Clinical Trials Paid Clinical Trials > Browse Categories > Medications / Interventions > Aa > Ampligen

Ampligen

Ampligen

All Categories Medications / Interventions » Aa » Ampligen


  • Safety Study of FluMist With and Without Ampligen

    Condition:   Influenza, Human
    Interventions:   Drug: FluMist + Poly I:Poly C12U;   Drug: FluMist + Poly I:Poly C12U;   Drug: FluMist + Poly I:Poly C12U;   Drug: FluMist + Poly I:Poly C12U;   Drug: FluMist + Placebo
    Sponsors:   Hemispherx Biopharma;   Hemispherx Biopharma
    Recruiting - verified May 2012
  • Vaccine Therapy in Combination With Ampligen® and/or Sargramostim in Patients With Stage II-IV HER2-Positive Breast Cancer

    Conditions:   HER2-positive Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
    Interventions:   Drug: Ampligen;   Biological: synthetic HER-2/neu peptide vaccine;   Biological: GM-CSF;   Other: laboratory biomarker analysis;   Other: immunoenzyme technique
    Sponsors:   Fred Hutchinson Cancer Research Center;   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)
    Recruiting - verified January 2012
  • Study of Ampligen in Chronic Fatigue Syndrome

    Condition:   Chronic Fatigue Syndrome
    Interventions:   Drug: Ampligen (poly I: poly C12U);   Drug: Poly I: Poly C12U
    Sponsors:   Hemispherx Biopharma;   Hemispherx Biopharma
    Recruiting - verified September 2011

Main Menu
Clinical Trial Categories
Clinical Trial Locations